Gadolinium Orthovanadate Nanoparticles Normalizes Glycemia, Insulin Resistance, and Glucose Tolerance in Rats with Experimental Type 2 Diabetes Mellitus
{{output}}
The effect of orally administered gadolinium-europium orthovanadate nanoparticles (GdVO4:Eu3+ NPs) on the course and progression of diabetes and vascular malfunction in rats with type 2 diabetes (T2DM) was studied. Long-term GdVO4:Eu3+ NPs administration with ... ...
